Adiponectin as predictor for diabetes among pre-diabetic groups

Endocrine

Volumn 44, Issue 2, 2013, Pages 411-418

  Kim, Hyon Suk ^a   Jo, Jaeseong ^b   Lim, Jung Eun ^b   Yun, Young Duk ^c   Baek, Soo Jin ^c   Lee, Tae Yong ^d   Huh, Kap Bum ^e   Jee, Sun Ha ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c National Health Insurance Service   (South Korea)

^d Chungnam National University College of Medicine   (South Korea)

^e Huh's Diabetes Center   (South Korea)

Author keywords

Adiponectin; Cohort study; Diabetes; Impaired fasting glucose

Indexed keywords

ADIPONECTIN; GLUCOSE;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SOUTH KOREA; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; PROGNOSIS; REPUBLIC OF KOREA;

EID: 84885638544     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-9890-5     Document Type: Article

References (27)

1. M.G. Kovar, M.I. Harris, W.C. Hadden, The scope of diabetes in the United States population. Am J Pub Health 77, 1549-1550 (1987)
2. S.H. Jee, H. Ohrr, J.W. Sull, J.E. Yun, J. Min, J.M. Samet, Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293, 194-202 (2005)
3. Bergman M. Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine. (2012). doi: 10.1007/s12020-012-9830-9 [Epub ahead of print]
4. K.H. Chun, Evidence-based management and treatment of high-risk individuals with pre-diabetes. J Korean Med Assoc 54, 1020-1027 (2011)
5. K.T. Chen, C.J. Chen, E.W. Gregg, G. Imperatore, K.M. Narayan, Impaired fasting glucose and risk of diabetes in Taiwan: follow-up over 3 years. Diabetes Res. Clin. Pract. 60, 177-182 (2003)
6. S.L. Edelstein, W.C. Knowler, R.P. Bain, A. Reubin, E.L. Barrett-Connor, G.K. Dowse et al., Predictors of progression from impaired glucose tolerance to NIDDM: An analysis of six prospective studies. Diabetes 46, 701-710 (1997)
7. M.I. Harris, Impaired glucose tolerance in the U.S. population. Diabetes Care 12, 464-474 (1990)
8. S.S. Rasmussen, C. Glümer, A. Sandbaek, T. Lauritzen, K. Borch-Johnsen et al., Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark. Diabetologia 51, 249-257 (2008)
9. S. Li, H.J. Shin, E.L. Ding, R.M. van Dam, Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302, 179-188 (2009)
10. C. Heidemann, Q. Sun, R.M. van Dam, J.B. Meigs, C. Zhang, S.S. Tworoger et al., Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann. Intern. Med. 149, 307-316 (2008)
11. N. Zhu, J.S. Pankow, C.M. Ballantyne, D. Couper, R.C. Hoogeveen, M. Pereira et al., High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study. J. Clin. Endocrinol. Metab. 95, 5097-5104 (2010)
12. J.R. Kizer, A.M. Arnold, D. Benkeser, J.H. Ix, L. Djousse, S.J. Zieman et al., Total and high-molecular-weight adiponectin and risk of incident diabetes in older people. Diabetes Care 35, 415-423 (2012)
13. Y. Li, H. Yatsuya, H. Iso, H. Toyoshima, K. Tamakoshi, Inverse relationship of serum adiponectin concentration with type 2 diabetes mellitus incidence in middle-aged Japanese workers: six-year follow-up. Diabetes Metab Res Rev 28, 349-356 (2012)
14. A.G. Tabák, M. Carstensen, D.R. Witte, E.J. Brunner, M.J. Shipley, M. Jokela et al., Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study. Diabetes Care 35, 2540-2547 (2012)
15. S.Y. Kim, S.J. Lee, H.K. Park, J.E. Yun, M. Lee, J. Sung et al., Adiponectin is associated with impaired fasting glucose in the non-diabetic population. Epidemiol Health 33, e2011007 (2011)
16. S.H. Jee, S. Lee, S. Min, J. Park, H.S. Kim, S.Y. Kim et al., Development of ELISA-kit of quantitative analysis for adiponetin and their correlation with cardiovascular risk factors. Korean J Epidemiol 29, 165-175 (2007)
17. S.H. Jee, A.W. Foong, N.W. Hur, J.M. Samet, Smoking and risk for diabetes incidence and mortality in Korean men and women. Diabetes Care 33, 2567-2572 (2010)
18. H.K. Kim, C.H. Kim, E.H. Kim, S.J. Bae, J. Choe, J.Y. Park, et al. Impaired fasting glucose and risk of cardiovascular disease in Korean men and women: The Korean Heart Study. Diabetes Care. (2012). doi: 10.2337/dc12-0587 [Epub ahead of print]
19. O.F. Khabour, S.H. Wehaibi, S.I. Al-Azzam, K.H. Alzoubi, Z.J. El-Akawi. Association of adiponectin with hypertension in type 2 diabetic patients: the gender effect. Clin Exp Hypertens. (2012). doi: 10.3109/10641963.2012.732645 [Epub ahead of print]
20. M. Azrad, B.A. Gower, G.R. Hunter, T.R. Nagy. Racial differences in adiponectin and leptin in healthy premenopausal women. Endocrine. (2012). doi: 10.1007/s12020-012-9797-6 [Epub ahead of print]
21. K. Rabe, M. Lehrke, K.G. Parhofer, U.C. Broedl, Adipokines and insulin resistance. Mol. Med. 14, 741-751 (2008)
22. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, K. Tobe, Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116, 1784-1792 (2006)
23. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley et al., Hypoadiponectinemia in obesity and type 2 diabetes:close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86, 1930-1935 (2001)
24. O. Tschritter, A. Fritsche, C. Thamer, M. Haap, F. Shirkavand, S. Rahe et al., Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52, 239-243 (2003)
25. C. Menzaghi, V. Trischitta, A. Doria, Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 56, 1198-1209 (2007)
26. W. Du, Q. Li, Y. Lu, X. Yu, X. Ye, Y. Gao et al., Genetic variants in ADIPOQ gene and the risk of type 2 diabetes: a case-control study of Chinese Han population. Endocrine 40, 413-422 (2011)
27. T. Pischon, G.S. Hotamisligli, E.B. Rimm, Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin. Chem. 49, 650-652 (2003)